A cross-sectional study in Qatar reported a higher prevalence of metabolic syndrome among psychiatric patients taking antipsychotics versus a control group without psychiatric illness, but the difference did not reach statistical significance (31.9% vs 22.8%, p = 0.12) [ 9 ].
← all excerpts
Quality of diabetes care in patients with schizophrenia: a case-control study in Qatar.
1
0.1200
0.1200